Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Sungen Bio-Tech is a prominent Chinese biotechnology company focused on the research, development, and manufacturing of high-value nutritional and pharmaceutical ingredients via advanced fermentation technology. Established in 1989, the company has become a global leader in the production of natural Vitamin K2 (MK-7) and Nattokinase, holding a significant portfolio of patents and international certifications. Sungen Bio provides high-purity raw materials to the global dietary supplement and functional food markets, primarily targeting cardiovascular and bone health. Their expertise extends to the production of poly-gamma-glutamic acid (γ-PGA) for use in the cosmetics and agricultural sectors. The company is headquartered in Shantou and is listed on the Chinese NEEQ market. Sungen Bio is recognized for its green manufacturing processes, utilizing non-GMO strains and chemical-free extraction methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Sungen Bio.